Your session is about to expire
← Back to Search
Shear Wave Elastography Imaging for Post-Surgery Kidney Assessment
N/A
Recruiting
Led By Ahmed Zaky, MD, MPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Structurally normal kidney on renal ultrasound
No history of diabetes or hypertension
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the time of informed consent being given to 96 hours after consent being given
Awards & highlights
Study Summary
This trial looks at using a new type of imaging to better distinguish between those who have had a recent surgery on their kidneys and those who haven't.
Who is the study for?
This trial is for adults with healthy kidneys, normal kidney function (eGFR > 60 ml/min/m^2), and a BMI under 27 kg/m^2. It's not for those with diabetes or hypertension, prisoners from correctional facilities, transplant or ventricular assist device patients, children under 19 years old or weighing less than 50 kg if age is unknown.Check my eligibility
What is being tested?
The study investigates the use of Shear Wave Elastography—a type of ultrasound—to tell apart Acute Kidney Injury in individuals after vascular surgery from that in healthy people.See study design
What are the potential side effects?
Shear Wave Elastography is generally considered safe but may include discomfort during the procedure. As it's non-invasive, significant side effects are rare.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidneys are normal on ultrasound.
Select...
I have never had diabetes or high blood pressure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the time of informed consent being given to 96 hours after consent being given
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the time of informed consent being given to 96 hours after consent being given
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic factor of Shear Wave Elastography
Trial Design
2Treatment groups
Experimental Treatment
Group I: Vascular Surgery SubjectsExperimental Treatment1 Intervention
Group II: Healthy ControlsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shear Wave Elastography
2020
Completed Phase 2
~560
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,304 Total Patients Enrolled
9 Trials studying Acute Kidney Injury
2,887 Patients Enrolled for Acute Kidney Injury
Ahmed Zaky, MD, MPHPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a condition that makes it difficult to see your kidneys with ultrasound.Your kidney function, measured by the estimated glomerular filtration rate, is above a certain level.My upcoming procedure does not involve vascular surgery.I have severe kidney problems or am on dialysis.My kidneys are normal on ultrasound.I am under 19 years old or weigh less than 50 kg.You weigh more than what is considered healthy for your height.I have never had diabetes or high blood pressure.I am on the list for a heart transplant due to end-stage heart disease.I am undergoing an emergency medical procedure.You are using a ventricular assist device.People who have had an organ transplant.People who have recently been in prison.Your body mass index (BMI) is less than 27.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Controls
- Group 2: Vascular Surgery Subjects
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical research still available to participants?
"Affirmative. Records on clinicialtrials.gov suggest that this trial is enrolling willing participants, having been first posted on January 15th 2020 and recently updated on September 12th 2022. The experiment requires 50 individuals from one location to participate."
Answered by AI
How many individuals are currently registered for this research program?
"Affirmative. Clinicaltrials.gov states that this research effort, which was first posted on January 15th 2020, is currently recruiting participants. In total, 50 people are required to join the experiment at a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger